Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome [7]

Archives of Dermatology

Volumn 142, Issue 2, 2006, Pages 247-248

  Young, Priya K ^a   Ruggeri, Sun Young ^b   Galbraith, Sheila ^b   Drolet, Beth A ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

CASE REPORT; DELAYED HYPERSENSITIVITY; ECZEMA; FEMALE; HUMAN; LETTER; PAPULOVESICULAR RASH; PRIORITY JOURNAL; SCHOOL CHILD; STEVENS JOHNSON SYNDROME;

CHILD; DIAGNOSIS, DIFFERENTIAL; ECZEMA, DYSHIDROTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; STEVENS-JOHNSON SYNDROME;

EID: 33244463773     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.142.2.247     Document Type: Letter

References (5)

1. Metry D, Jung P, Levy M. Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of the literature. Pediatrics. 2003;112:1430-1436.
2. Dalakas M. Intravenous immune globulin therapy for neurologic diseases. Ann Intern Med. 1997;126:721-730.
3. Iannaccone S, Sferrazza B, Quattrini A, Smirne S, Ferini-Strambi L. Pompholyx (vesicular eczema) after IV immunoglobulin therapy for neurologic disease. Neurology. 1999;53:1154-1155.
4. Uyttendaele H, Obadiah J, Grossman M. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy. J Drugs Dermatol. 2003;2:337-341.
5. Sorensen P, Wanscher B, Jensen C, et al. Intravenous immunoglobulinGreduces MRI activity in relapsing multiple sclerosis. Neurology. 1998;50:1273-1281.